Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results

Go back to Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
(NASDAQ: DSGN) Delayed: 15.26 +0.16 (1.06%)
Previous Close $15.10    52 Week High
Open $14.97    52 Week Low
Day High $15.39    P/E N/A 
Day Low $14.85    EPS
Volume 351,818